Jason A. Keyes

Chief Financial Officer at BlossomHill Therapeutics · 1 reported transaction in 1 company · latest trade Aug 10, 2026

Their record

No purchases old enough to measure yet.


BlossomHill TherapeuticsBLSM	Bought $11.2K · 700 shares	Aug 10, 2026	S&P 500 −0.5%thru Oct 29

Aug 10, 2026 · BLSM

$11.2K

S&P 500 −0.5%thru Oct 29

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at BlossomHill Therapeutics · 1 reported transaction in 1 company · latest trade Aug 10, 2026

No purchases old enough to measure yet.


BlossomHill TherapeuticsBLSM	Bought $11.2K · 700 shares	Aug 10, 2026	S&P 500 −0.5%thru Oct 29

Aug 10, 2026 · BLSM

$11.2K

S&P 500 −0.5%thru Oct 29

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.